Merger

Facet Biotech Stockholders Reject Biogen Idec Tender Offer

December 17, 2009

The company will continue to pursue other opportunities
 

Silence Therapeutics to Merge with Intradigm Corp

December 16, 2009

Merger to Create Leading RNAi Therapeutics Company
 

Biogen Idec Stands Ready to Close Its $17.50 Per Share All-Cash Tender Offer for Facet Biotech

December 14, 2009

Biogen Idec Reminds Stockholders to Tender Their Shares by December 16, 2009
 

Pfizer And Wyeth Become One: Working Together For A Healthier World

October 16, 2009

Establishes and Expands Leadership in Human, Animal and Consumer Health
 
 

Biogen Idec Commences Tender Offer for Facet Biotech

September 21, 2009

Offers to Acquire All Outstanding Shares of Facet for $14.50 Per Share in Cash
 

Noven and Hisamitsu Enter into Definitive Merger Agreement

July 14, 2009

Hisamitsu to Commence All-Cash Tender Offer for 100% of Noven Shares
 

CombinatoRx and Neuromed Sign Merger Agreement

July 01, 2009

Merger to Create a Sustainable Biotechnology Company